Fund Faculdade Regional Med Sao Jose Rio Preto

São José do Rio Preto, São Paulo 15090-000

1 studies enrolling now · 3 studies all time

What they study most

Extensive Stage Small-cell Lung Cancer, MTAP-deleted NSCLC, Non-small Cell Lung Cancer, Small-cell Lung Cancer, Thoracic Tumors

Studies at this site

• A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC) — Recruiting now
• Anvumetostat Alone or in Combination With Other Therapies in Subjects With Advanced Thoracic Tumors With Homozygous MTAP-deletion (Master Protocol) (MTAPESTRY 104). — Running, not enrolling
• A Phase 2 Study of Anvumetostat in Participants With MTAP-deleted Advanced NSCLC (MTAPESTRY 201) — Running, not enrolling